FDA Increases Testing For Heavy Metals In Baby Formula
By I. Edwards HealthDay Reporter
THURSDAY, March 20, 2025 -- The U.S. Food and Drug Administration (FDA) is stepping up testing for heavy metals in infant formula and reviewing key nutrients required in these products, federal health officials said.
"The FDA will use all resources and authorities at its disposal to make sure infant formula products are safe and wholesome for the families and children who rely on them," Health and Human Services Secretary Robert F. Kennedy Jr. said in a statement.
Kennedy recently met with top executives from formula makers, including Abbott Laboratories, which produces Similac, and Reckitt Benckiser, the company behind Enfamil, according to a social media post from HHS.
The FDA will also conduct a comprehensive review of infant formula nutrients while ramping up testing for heavy metals and other contaminants, CBS News reported. The actions are being dubbed Operation Stork Speed.
"The FDA is deeply committed to ensuring that moms and other caregivers of infants and young children and other individuals who rely on infant formula for their nutritional needs have confidence that these products are safe, consistently available, and contain the nutrients essential to promote health and wellbeing during critical stages of development and life," Acting FDA Commissioner Dr. Sara Brenner said in a statement.
The action dovetails with findings of a Consumer Reports investigation released Tuesday, which found potentially harmful chemicals -- including acrylamide, arsenic, BPA, lead, and PFAS -- in nearly half of the 41 infant formula products tested.
Some products had low or no levels detected.
"We look forward to seeing the details of how they intend to implement the plan, and we hope the FDA is providing adequate resources and staffing to actually follow through with these promises," Brian Ronholm, director of food policy at Consumer Reports, said in a statement.
Concerns about infant formula safety have been heightened since 2022, when FDA inspections found bacteria linked to two infant deaths at Abbott's Sturgis, Mich., plant.
The plant's temporary closure led to a nationwide formula shortage, causing stress for millions of families who depend on formula to feed their babies.
Roughly 1 in 5 newborns in the U.S. start on formula, making it a crucial source of nutrition in the first months of life.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-21 06:00
Read more

- MS Patients May Benefit From Eating More Fish
- Rewards of Tight Blood Pressure Control Outweigh Risks, Trial Finds
- 2016 to 2023 Saw Increase in NICU Admission Rate
- FDA Approves Miudella (copper intrauterine system) for the Prevention of Pregnancy
- Tirzepatide, Semaglutide Not Cost-Effective at Current Prices
- GLP-1 Drugs Improve Outlook For Kidney Transplants
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions